background image

Paid Clinical Trials Cincinnati

Discover 1,160 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Lumateperone

Recruiting
PHASE3

Sponsor:

Intra-Cellular Therapies, Inc.

Location:

Cincinnati OH, Indianapolis IN, Garfield OH, Avon Lake OHshow 31 more

Code:

NCT06372964

Conditions

Bipolar Depression

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

Lumateperone

Placebo

Observational Study

Recruiting

Sponsor:

Corcept Therapeutics

Location:

Covington KY, Cincinnati OH, Columbus OH, Troy MIshow 25 more

Code:

NCT06829537

Conditions

Resistant Hypertension

Hypercortisolism

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Tirzepatide

Recruiting
PHASE3

Sponsor:

Eli Lilly and Company

Location:

Covington KY, Indianapolis IN, Lima OH, Springfield ILshow 27 more

Code:

NCT06914895

Conditions

Type 1 Diabetes

Obesity

Overweight

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tirzepatide

Placebo

FT825/ONO-8250 & Monoclonal Antibodies

Recruiting
PHASE1

Sponsor:

Fate Therapeutics

Location:

Cincinnati OH, Columbus OH, Detroit MI, Nashville TNshow 10 more

Code:

NCT06241456

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FT825

Fludarabine

Cyclophosphamide

Bendamustine

Docetaxel

Observational Study

Recruiting

Sponsor:

University of Cincinnati

Location:

Cincinnati OH

Code:

NCT06366256

Conditions

Speech Sound Disorder

Eligibility Criteria

Sex: All

Age: 7 - 17

Healthy Volunteers: Not accepted

Interventions

Traditional ultrasound biofeedback

Simplified ultrasound biofeedback

Interested in new trials?

Get alerts for new trials in your area by subscribing now

By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.

MPH HCl ER

Recruiting
PHASE3

Sponsor:

Ironshore Pharmaceuticals and Development, Inc

Location:

Cincinnati OH, Saint Charles MO, Decatur GA, Memphis TNshow 9 more

Code:

NCT06431256

Conditions

Attention Deficit Hyperactivity Disorder

Eligibility Criteria

Sex: All

Age: 4 - 5

Healthy Volunteers: Not accepted

Interventions

HLD200 methylphenidate hydrochloride capsules

Placebo HLD200 capsules

Neoadjuvant Chemotherapy vs. Chemoradiotherapy

Recruiting
PHASE3

Sponsor:

Canadian Cancer Trials Group

Location:

Cincinnati OH, West Chester OH, Franklin OH, Centerville OHshow 52 more

Code:

NCT06205485

Conditions

Rectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Leucovorin

Oxaliplatin

Fluoruracil

Capecitabine

Radiation

Nutrition

Recruiting

Sponsor:

Jaeb Center for Health Research

Location:

Cincinnati OH, Lexington KY, Cleveland OH, Chicago ILshow 14 more

Code:

NCT05639556

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BMI and lean mass index from DXA

Anthropometric Measurements

Hand-grip strength

Six-minute walk Test

Sit-to-Stand Test

BLU-263

Recruiting
PHASE2
PHASE3

Sponsor:

Blueprint Medicines Corporation

Location:

Cincinnati OH, Ann Arbor MI, Buffalo NY, Birmingham ALshow 6 more

Code:

NCT04910685

Conditions

Indolent Systemic Mastocytosis

Monoclonal Mast Cell Activation Syndrome

Smoldering Systemic Mastocytosis

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

Elenestinib

Placebo

Ofatumumab

Recruiting
PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Cincinnati OH, Centerville OH, Indianapolis IN, Columbus OHshow 42 more

Code:

NCT06869785

Conditions

Relapsing Multiple Sclerosis (RMS)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Ofatumumab approved dose

Ofatumumab new dose